Quantcast
Last updated on April 21, 2014 at 11:58 EDT

Latest Virus Stories

2014-04-03 13:07:48

Study finds increased risk of stroke following shingles, suggests antiviral treatment may Patients' risk of stroke significantly increased following the first signs of shingles, but antiviral drugs appeared to offer some protection, according to a new study in Clinical Infectious Diseases, now available online. People with shingles, an often painful skin rash caused by the same virus that causes chickenpox, had a higher stroke risk in the first 6 months after shingles symptoms appeared;...

Nano-paper Filter Removes Virus Particles
2014-04-01 16:31:23

Uppsala University Nanotechnology and Functional Materials, Uppsala University have developed a paper filter, which can remove virus particles with the efficiency matching that of the best industrial virus filters. The paper filter consists of 100 percent high purity cellulose nanofibers, directly derived from nature. The research was carried out in collaboration with virologists from the Swedish University of Agricultural Sciences/Swedish National Veterinary Institute and is published...

'Unprecedented' Ebola Outbreak Sweeping Across Parts Of West Africa
2014-04-01 10:23:22

Lawrence LeBlond for redOrbit.com - Your Universe Online An “unprecedented” outbreak of Ebola hemorrhagic fever (EHF) has spread throughout Guinea and beyond with more than a hundred patients confirmed to have the highly-infectious and equally as deadly disease. The first reports from the World Health Organization (WHO) surfaced just over a week ago on March 23, after the Ministry of Health of Guinea reported to the UN health arm that the disease was rapidly spreading throughout the...

2014-03-25 23:30:00

Markets Research Reports.biz added deep and professional market research reports on "Global Cancer Vaccines Competitor Analysis And Market Research" Market Analysis and Overview. Albany, NY (PRWEB) March 25, 2014 The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. Purchase of the downloadable pdf report includes a 6-month online access to...

2014-03-25 08:30:19

Modified MIC Proteins as Targeted Immunotherapy for Cancer and Virus-Infected Cells SOUTH SAN FRANCISCO, Calif., March 25, 2014 /PRNewswire/ -- AvidBiotics Corp., a privately held biotechnology company developing novel, non-antibody proteins targeting cancer and virus-infected cells, today announced that it has received an issued patent from the U.S. Patent and Trademark Office covering the targetable immunotherapeutic platform being developed by the company. US Patent No....

2014-03-25 08:29:52

Resistance to current drugs spurs treatment innovation in influenza, respiratory syncytial virus, chlamydia and gonorrhoea LONDON, March 25, 2014 /PRNewswire/ -- The available antivirals for commonly occurring infections such as respiratory syncytial virus (RSV) and influenza are characterised by variable response, poor tolerability and suboptimal dosing regimens, limiting their regular use and efficacy. Likewise, the development of resistance to almost every recommended antibiotic...

2014-03-21 16:23:10

Increase in Concentration of Newly Identified Replikin Beetoxingene Preceded Current CCD Outbreaks; Beetoxingene Sequences are CCD Blocker and Vaccine Candidates LONDON, March 21, 2014 /PRNewswire/ -- Bee Colony Collapse Disorder (CCD) is increasing with unknown cause(s). There is no effective treatment or prevention of CCD. Increasing loss of bee colonies since 2005 is resulting in the loss of bee pollination which poses a threat to food production worldwide....

2014-03-13 23:02:55

Study Suggests Targeting Molecular Interaction of Virus and Host Protein May Arrest This Lethal Virus New York, NY (PRWEB) March 13, 2014 A protein that normally protects cells from environmental stresses has been shown to interact Marburg virus VP24, allowing the deadly Marburg virus to live longer and replicate better, according to a preclinical study led by scientists at the Icahn School of Medicine at Mount Sinai. The investigators say that deciphering the molecular details of how...

2014-03-10 23:02:44

New research report “Viral Molecular Diagnostics: Market Developments, Growth Areas and Opportunities” worked out by Biopharm Reports is now available at MarketPublishers.com. London, UK (PRWEB) March 10, 2014 On the whole, the viral diagnostic tests are divided into the three main groups – indirect examination following virus isolation, serology, and direct detection. Direct methods are generally used to test virus particles, viral nucleic acids or virus antigen; whilst, indirect...

2014-03-10 16:32:39

RNActive® Vaccines Offer Excellent Conditions for Cost-Effective Worldwide Distribution TUBINGEN, Germany and BRUSSELS, March 10, 2014 /PRNewswire/ -- CureVac, a German clinical stage biopharmaceutical company, today announced that it has won the inaugural European Commission Vaccine Prize. The EU has dedicated the prize of two million Euros in an effort to stimulate innovative solutions for vaccine transportation and storage where cold chain cannot be guaranteed. CureVac's...


Latest Virus Reference Libraries

0_57c89d5bd133fff5bf10b17b705f87c1
2011-03-04 17:38:30

Yellow fever is an acute viral hemorrhagic disease with a 40 to 50 nm enveloped RNA virus with positive sense of the Flaviviridae family. It is transmitted by the bite of female mosquitoes and is found in tropical and subtropical areas in South America and Africa, but not in Asia. Primates and a few kinds of mosquitoes are the only known hosts. The origin of the disease is most likely Africa. From there it was introduced to South America through the slave trade in the 16th century. There...

70_abea42e7e9120224289c31dda90b6e25
2011-03-03 21:34:50

Rubella virus is the cause of congenital rubella syndrome when infection occurs during the first weeks of pregnancy. Humans are the only known host of this virus. It is the only member of the genus of Rubivirus and belongs to the family of Togaviridae. Members of the Togaviridae family typically have a genome of single-stranded RNA of positive polarity which is enclosed by an icosahedral capsid. This genome has a length of about 9,757 nucleotides and encodes for two non-structural as well...

0_c4753f392575c29d1886d90b7b382782
2011-02-23 21:28:34

A virus is a small infectious agent that replicates inside the living cells of organisms. It is a small infectious agent that can replicate only inside the living cells of organisms. Most are too small to be seen by anything but a microscope and they infect all organisms from animals to plants to bacteria. The first one discovered was the tobacco virus in 1898. Since then around 5,000 viruses have been described in detail although there are millions of different types. They are found in...

70_8c49b7354584ec16683e38a21f19f6de
2011-02-23 21:18:56

Vaccinia virus (VACV or VV) is a large, complex, enveloped virus belonging to the poxvirus family. It is well-known for its role in eradicating smallpox. It was the first human disease to to successfully be eradicated by science. The World Health Organization was the one who completed the endeavor. The vaccinia virus saw renewed interest in the early 21st century due to concerns about the smallpox virus being used as an agent for bioterrorism. They can be divided into four types:...

70_dd0fb65b7366091c1e0897e58f1798fa
2011-02-23 20:58:48

Simian immunodeficiency virus (SIV), also known as African Green Monkey virus, is a retrovirus able to infect at least 33 species of African primates. SIV has been present in monkeys and apes for at least 32,000 years, probably longer. Strains from two of these primate species have crossed the barriers into humans resulting in HIV-2 and HIV-1. Contraction involves contact with the blood of chimps that are often hunted for bushmeat in Africa. SIV infections appear in many cases to be...

More Articles (15 articles) »